Background: Acute Kidney Injury (AKI) is an unsolved clinical problem in critical care patients with a high mortality rate, increasing incidence, and no definitive therapy. We studied the incidence, risk factors, and mortality associated with AKI in ICU patients. Materials and Methods: In a prospective study, patient demographics, reason for hospitalization, reason for ICU admission, Length of ICU stay, laboratory data, and Vital signs were recorded in prepared forms during the ICU stay. AKI was defined as an increase in serum creatinine (SCr) of ≥ 0.3mg/dl from the baseline. Results: A total of 200 patients who were enrolled in our study; 134 (67%) did not develop AKI during their ICU stay while 66 (33%) developed AKI (SCr ≥ 0.3) according to the AKIN definition. Patients with AKI had higher APACHE II scores (12.3±5.6 vs. 6.9±3.6; P< 0.001), longer ICU stays (7.6±7.6 vs. 3.7±2.8 days respectively; P< 0.001), and higher mortality (19.7% vs. 0.7%; P< 0.001).
INTRODUCTION
Acute Kidney Injury continues to remain a significant problem in hospitalized patients and has a high mortality rate. Furthermore, the incidence of AKI continues to increase and currently there is no definitive therapy for it (1) . It is a complex functional or structural disorder, which occurs abruptly, usually within 48 hours of hospitalization and is defined as a sudden onset of reduced kidney function (2) . Previous studies highlight the importance of early recognition of AKI as well as the association of AKI with increased mortality in hospitalized patients (3) . The clinical spectrum of AKI ranges from slight elevations in serum creatinine to anuric renal failure. Acute kidney injury causes disturbances in fluid balance, electrolytes, and acid-base status due to decreased solute clearance and decreased glomerular filtration rate (GFR) (urine <0.5 ml/kg/hr for >6 hrs). In critically ill patients the dilution of SCr by fluid accumulation may lead to underestimation of the severity of AKI and delayed diagnosis of AKI (4) .
TANAFFOS
Oliguria is common in ICU patients and might be better in identifying patients with AKI compared to serum creatinine criterion (5) . There is an association between AKI and patient outcomes. However, associated organ failure had a greater impact on prognosis than severity of AKI (6). 5-7% of the hospitalized patients and 30% of ICU patients develop AKI (7) . Although risk factors for AKI are not fully understood, it has severe consequences (8) . The reported mortality rate associated with AKI is 20-90%, which has not changed significantly over the last 15 years.
Mortality rate depends on the patient's general condition, age, and the severity of illness. Among patients who are admitted to the ICU because of AKI, older patients experience higher rates of AKI. There used to be no uniform definition of AKI in the literature until the Acute Kidney Injury Network (AKIN) developed a new definition based on scientific investigation (9) . As minor increases in serum creatinine (≥0.3mg/dl) are associated with increased mortality, AKIN chose changes in SCr as the basis of their definition of AKI (10) . Besides mortality, AKI increases other morbidities, which are associated with increased costs (11) , increased length of hospital stay (12, 13) , and increased risk of developing chronic kidney disease (CKD), including end-stage kidney disease (14) (15) (16) (17) .
Despite available evidence about the impact of AKI on morbidity and mortality, there are inadequate data on epidemiology and outcomes associated with AKI in different parts of the world. Besides, the definition of AKI needs to be validated in order to accurately predict patient outcome. As more studies are conducted our understanding of the disease, its risk factors, and associated mortality will improve. In the current study we investigated the incidence, risk factors, and mortality associated with AKI in the ICU population.
MATERIALS AND METHODS

Study Design
We conducted a prospective observational study from Laboratory tests including electrolytes, blood urea nitrogen and serum creatinine were measured at baseline (before admission), at 6 AM every day during ICU stay, when AKI was diagnosed, and at 24 and 48 hours after AKI was diagnosed. The ability of AKIN criteria for predicting hospital mortality was compared to that of the APACHE II score, age, and multi-organ failure.
Patient Selection
Acute kidney injury was defined as an increase in serum creatinine (SCr) of ≥ 0.3mg/dl from the baseline.
The lowest value of SCr during the ICU stay or within 24 hours before admission was considered the baseline SCr.
Patients were categorized into two groups: AKI and Non-AKI. The patients in the AKI group had an increase in SCr of ≥ 0.3 mg/dL during their ICU stay as previously specified. Intensive care unit mortality, length of ICU stay, and renal replacement therapy (RRT) use were compared between the two groups.
Statistical analysis
Statistical analysis was performed using SPSS version 16 (SPSS Inc., Chicago, IL). All continuous data are presented as mean ± SD. Student's t-test was applied to compare normally distributed means. Chi-squared or We did not find a significant difference between LOS in dead and alive patients in the AKI group. Multivariate logistic regression analysis showed that AKI is a powerful predictor of LOS. Acute kidney injury, defined according to the AKIN criteria, can predict mortality with 71% specificity and 93% sensitivity. APACHE II score can predict ICU mortality with 75% specificity and 93% 
DISCUSSION
The purpose of this study was to investigate the outcomes associated with AKI in ICU patients and to determine the predictors of mortality in patients who develop AKI during their ICU stay in a prospective observational study, using the AKIN criteria to diagnose AKI. Oliguria lasting for more than 12 hours and ≥ 3 more episodes of oliguria are associated with increased mortality and are sensitive markers for AKI and are associated with adverse outcomes in ICU patients (18) . Previously RIFLE criteria were used to diagnose kidney injury (19) .
However, newer evidence suggests that smaller rises in SCr (≥ 0.3 mg/dL) should be used to diagnose kidney injury (20) . A simplified definition of AKI which uses elevations in SCr is more helpful and advantageous than hourly measurements urine output and is able to predict patient outcomes more accurately. reported 77% specificity (71% in our study). This yielded a
Youden index of 0.64 for our study in comparison to a Youden index of 0.33 in Barrantes's study. High sensitivity and specificity, as well as high Youden index make AKIN criteria for AKI highly predictive of ICU mortality.
Our study had several limitations including small sample size from a single center, even though we tried to include a broad range of ICU patients (post surgical patients, patients with coronary disease, and those with respiratory complications, etc.) as detailed in Table 2 .
Moreover, we excluded patients with pre-existing kidney complications. Additionally, we selected patients with normal baseline SCr. It is unclear whether baseline SCr levels affect patient outcomes or not.
In conclusion, we investigated AKIN criteria for AKI as predictor of ICU mortality and demonstrated that AKIN criteria is clinically valid and can be a good predictor of mortality and patient outcomes in addition to APACHE II score in ICU patients. Future studies with larger sample sizes are needed to confirm our findings and validate AKIN criteria for AKI. These indexes help patients at risk of AKI receive closer attention and perhaps have better outcomes.
